Surendra Sharma

Company: Outlook Therapeutics

Job title: Senior Vice President, Medical Affairs

Seminars:

ONS-5010: The First On-Label Bevacizumab Treatment for Wet AMD 9:30 am

Addressing regulatory challenges to meet FDA approval Leveraging EMA support to establish ONS-5010 as a global standard for wet AMD treatment Explaining the product details, offering an affordable and effective alternative to compete in the crowded anti-VEGF market and reshape retinal care paradigmsRead more

day: Day One

Panel Discussion: How Can We Practically Implement New Treatments for Retinal Vascular Disorders, Streamlining Clinical Trials to Set Yourself Up for Success? 12:00 pm

How can you streamline trial design, incorporating new drug and technology advancements, to ensure a smoother transition through clinical phases for retinal therapies? What are the best strategies for forming partnerships and collaborations to support clinical development and commercialization efforts? How can patient engagement and feedback be integrated into the development process to enhance the…Read more

day: Day One